OpenAlex
PricingAboutJobs
Log inGet started
Work

Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease

HTML PDF

Year: 2013
Type: article
Source: Gastroenterology
DOI: 10.1053/j.gastro.2013.12.025
Authors: Mark T. Osterman, William J. Sandborn, Jean-Frederic Colombel, Anne M. Robinson, Winnie Lau, Bidan Huang, Paul F. Pollack, Roopal B. Thakkar, James D. Lewis
Institutions: University of Pennsylvania, University of California San Diego, AbbVie (United States)
Language: English

Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: adalimumab, Crohn's disease, cancer risk, non-melanoma skin cancer, combination therapy, immunomodulators, anti-TNF therapy, cancer incidence, standardized incidence ratio
SDG: Good health and well-being

Open Access status: bronze

Funder: AbbVie
OpenAlex ID: W2002647452
FWCI: 18.35
Cites: 39
Cited by: 205
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security